-
Delaware’s Prescription Opioid Settlement Fund continues to grow, but distribution of those funds will likely not resume until next year.
-
After months of anticipation, outside consulting agency Social Contract delivers its recommendations to the Prescription Opioid Settlement Distribution Commission on how it can better allocate funding.
-
Delaware’s opioid use continues to trend downward, but concerns around youth vaping and marijuana and alcohol use are on the rise.
-
An external report examining the Prescription Opioid Settlement Distribution Commission’s grant process is expected in October following fraud concerns.
-
Opioid settlement grant recipients await delayed funding amid mass audits and outside consultancy evaluations.
-
The governing body of the Prescription Opioid Settlement Distribution Commission is working to revamp its internal controls and grant distribution guidelines following a run-in with fraud concerns.
-
The State Auditor’s office releases a public Prescription Opioid Settlement Tracker amid a mass audit of grant recipients.
-
Delaware’s federal delegation secures $375,000 for youth substance use prevention amid statewide prescription opioid settlement grant freezes.
-
The State Auditor’s Office sent a letter to the Prescription Opioid Settlement Distribution Commission saying it intends to audit 11 grant recipients following an alleged misuse of funds incident.
-
Lt. Gov. Bethany Hall-Long and Attorney General Kathy Jennings to hold community listening sessions on the opioid crisis in all three counties.